Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT00701805
Eligibility Criteria:
Inclusion Criteria:
* Patients who completed 12 weeks of Study M10-309 (NCT00667576).
Exclusion Criteria:
* Patients taking drugs that affect intact parathyroid hormone (iPTH), calcium, or bone metabolism.
* Patients with progressive malignancy or clinically significant hepatic disease.
* Patients who developed severe cerebrovascular/cardiovascular disease during the dose-response portion of the study (i.e., during M10-309, NCT00667576).
* Patients with uncontrolled diabetes during the dose-response portion of the study (i.e., during M10-309, NCT00667576).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT00701805
Study Brief:
Protocol Section:
NCT00701805